Urawa Naohito, Kobayashi Yoshinao, Araki Jun, Sugimoto Ryosuke, Iwasa Motoh, Kaito Masahiko, Adachi Yukihko
Division of Clinical Medicine and Biomedical Sciences, Department of Gastroenterology and Hepatology, Institute of Medical Science, Mie University Graduate School of Medicine, Mie 514-8507, Japan.
Oncol Rep. 2006 Oct;16(4):801-6.
UDP-glucuronosyltransferase (UGT) enzymes are responsible for the glucuronidation and detoxification of many endogenous or exogenous xenobiotics. Gilbert's syndrome (GS) and Crigler Najjar syndrome type 2 (CNS-II) are characterized by unconjugated hyperbilirubinemia due to reduced enzymatic activity of UGT1A1. Recent studies have demonstrated the frequent co-existence of UGT1A1 *28 (-53 [TA]6>7) with other polymorphisms of UGT1A6 and UGT1A7. This finding suggests the occurrence of linkage disequilibrium (LD) among UGT1A1, UGT1A6 and UGT1A7 polymorphisms. UGT1A1 *6 (211G>A, G71R) and UGT1A1 *28 are common in Asian populations. In the present study, we investigated the LD of UGT1A1 *6 and UGT1A1 *28 in relation to UGT1A6 and UGT1A7 polymorphisms. Exon 1 of UGT1A1, UGT1A6 and UGT1A7 was sequenced using genomic DNA isolated from peripheral leukocytes of 390 Japanese subjects. LD and haplotypes were analyzed using SNPAlyze ver. 5.0 software. UGT1A1 *6 had a strong LD in relation to UGT1A6 variants including 541A>G and 552A>C (D'=0.846-0.848, r(2)=0.413-0.438) and UGT1A7 variants including 387T>G, 391C>A, 392G>A and 622T>C (D'=0.667-0.858, r(2)=0.207-0.413). UGT1A1 *28 had a lower degree of LD than UGT1A1 *6 in relation to these variants (D'=0.245-0.401, r(2)=0.025-0.063). All the haplotypes with G71R lacked -53[TA]6>7. The present study showed for the first time that the LD of UGT1A1 *6 in relation to UGT1A6 and 1A7 polymorphisms is far stronger than UGT1A1 *28. The UGT1A1 *6 allele appears to be independent of the UGT1A1 *28 allele. Although patients with GS and CNS-II are believed to have good prognosis, a subgroup of GS or CNS-II patients with the UGT1A1 *6 polymorphism might be at risk of abnormal drug metabolism and of developing malignant disease.
尿苷二磷酸葡萄糖醛酸基转移酶(UGT)负责许多内源性或外源性异生物的葡萄糖醛酸化和解毒。吉尔伯特综合征(GS)和2型克里格勒 - 纳贾尔综合征(CNS-II)的特征是由于UGT1A1酶活性降低导致的非结合性高胆红素血症。最近的研究表明,UGT1A1 *28(-53 [TA]6>7)与UGT1A6和UGT1A7的其他多态性频繁共存。这一发现提示UGT1A1、UGT1A6和UGT1A7多态性之间存在连锁不平衡(LD)。UGT1A1 *6(211G>A,G71R)和UGT1A1 *28在亚洲人群中很常见。在本研究中,我们研究了UGT1A1 *6和UGT1A1 *28与UGT1A6和UGT1A7多态性的连锁不平衡情况。使用从390名日本受试者外周血白细胞中分离的基因组DNA对UGT1A1、UGT1A6和UGT1A7的外显子1进行测序。使用SNPAlyze ver. 5.0软件分析连锁不平衡和单倍型。UGT1A1 *6与UGT1A6变异体包括541A>G和552A>C(D'=0.846 - 0.848,r(2)=0.413 - 0.438)以及UGT1A7变异体包括387T>G、391C>A、392G>A和622T>C(D'=0.667 - 0.858,r(2)=0.207 - 0.413)存在很强的连锁不平衡。与这些变异体相比,UGT1A1 *28的连锁不平衡程度低于UGT1A1 *6(D'=0.245 - 0.401,r(2)=0.025 - 0.063)。所有携带G71R的单倍型均缺乏-53[TA]6>7。本研究首次表明,UGT1A1 *6与UGT1A6和1A7多态性的连锁不平衡远比UGT1A1 *28强。UGT1A1 *6等位基因似乎独立于UGT1A1 *28等位基因。尽管GS和CNS-II患者被认为预后良好,但携带UGT1A1 *6多态性的GS或CNS-II患者亚组可能存在药物代谢异常和发生恶性疾病的风险。